Scand J Clin Lab Invest. 2005;65(6):505-11.
Serum levels of angioregulatory mediators in healthy individuals depend on age and physical activity: studies of angiogenin, basic fibroblast growth factor, leptin and endostatin.
Bruserud O, Grovan F, Lindås R, Blymke Møinichen C, Osterhus KK.
Curr Drug Targets. 2005 Sep;6(6):631-46.
Proteomics in acute myelogenous leukaemia (AML): methodological strategies and identification of protein targets for novel antileukaemic therapy.
Sjøholt G, Anensen N, Wergeland L, Mc Cormack E, Bruserud Ø, Gjertsen BT.
Cytotherapy. 2005;7(4):328-33.
The viability of cryopreserved PBPC depends on the DMSO concentration and the concentration of nucleated cells in the graft.
Liseth K, Abrahamsen JF, Bjørsvik S, Grøttebø K, Bruserud Ø.
Curr Cancer Drug Targets. 2005 Jun;5(4):229-48.
Antiangiogenic therapy in acute myelogenous leukemia: targeting of vascular endothelial growth factor and interleukin 8 as possible antileukemic strategies.
Hatfield KJ, Olsnes AM, Gjertsen BT, Bruserud Ø.
J Cancer Res Clin Oncol. 2005 Jun;131(6):377-84. Epub 2005 Mar 18.
In vitro culture of human osteosarcoma cell lines: a comparison of functional characteristics for cell lines cultured in medium without and with fetal calf serum.
Bruserud O, Tronstad KJ, Berge R.
Cytometry B Clin Cytom. 2005 Mar;64(1):18-27.
CD34 expression in native human acute myelogenous leukemia blasts: differences in CD34 membrane molecule expression are associated with different gene expression profiles.
Oyan AM, Bø TH, Jonassen I, Ulvestad E, Gjertsen BT, Kalland KH, Bruserud O.
Transfusion. 2005 Feb;45(2):248-53.
Large-volume leukapheresis yields more viable CD34+ cells and colony-forming units than normal-volume leukapheresis, especially in patients who mobilize low numbers of CD34+ cells.
Abrahamsen JF, Stamnesfet S, Liseth K, Hervig T, Bruserud O.
Eur J Haematol. 2005 Jan;74(1):24-34.
Coculture of native human acute myelogenous leukemia blasts with fibroblasts and osteoblasts results in an increase of vascular endothelial growth factor levels.
Glenjen NI, Hatfield K, Bruserud Ø.
Leuk Res. 2005 Feb;29(2):185-96.
In vitro crosstalk between fibroblasts and native human acute myelogenous leukemia (AML) blasts via local cytokine networks results in increased proliferation and decreased apoptosis of AML cells as well as increased levels of proangiogenic Interleukin 8.
Ryningen A, Wergeland L, Glenjen N, Gjertsen BT, Bruserud O.